Czapińska-Ciepiela, Ewa K.
Łuszczki, Jarogniew
Czapiński, Piotr
Czuczwar, Stanisław J.
Lasoń, Władysław http://orcid.org/0000-0001-9640-2159
Article History
Received: 22 February 2024
Revised: 9 May 2024
Accepted: 11 May 2024
First Online: 22 May 2024
Declarations
:
: S.J.C. received financial support from Bayer, GlaxoSmithKline, Janssen, Novartis, and Sanofi-Aventis for lecturing. S.J.C. and J.Ł are also recipients of an unrestricted grant from GlaxoSmithKline. P.C. has participated in 72 industry-sponsored clinical trials as the principal investigator and in seven clinical trials as the country coordinator. He has received financial support from pharmaceutical companies for organizing 29 editions of the conference “Psychosocial Aspects of Epilepsy” and financial support from Allergan, Teva, and UCB Pharma for lecturing. E.K.C.C. received financial support from Allergan, Novartis, Teva, Angelini Pharma, and Pfizer for lecturing and has participated in 22 industry-sponsored clinical trials as a sub-investigator.